Document Actions
Document Actions

Discontinuation of Thioridazine tablets (Aldazine)

last modified 13/04/2007 09:32

Pharmaceutical company, Alphapharm, has announced it will discontinue supply of Aldazine 25mg, 50mg and 100mg tablets in Australia from August 2007.

The company has notified the Pharmacy Guild of Australia that it plans to stop producing the antipsychotic drug because it can no longer obtain a reliable supply of the active ingredient, thioridazine. Alphapharm estimates that its decision will affect 1000 Australian adult patients who rely on the medication to treat schizophrenia. The company says its actions follows that of international manufacturers who have already withdrawn the supply of thioridazine tablets because they believe that newer antipsychotic drugs were better for older patients. The Pharmacy Guild of Australia has urged patients to see their doctors as soon as possible to discuss alternative medicines to take.
National Mental Health Strategy
Multicultural Mental Health Australia is funded by the The Australian Government Department of Health and Ageing through the National Mental Health Strategy.
Site by Lime Factor
If you can read this text, it means you are not experiencing the Plone design at its best. Plone makes heavy use of CSS, which means it is accessible to any internet browser, but the design needs a standards-compliant browser to look like we intended it. Just so you know ;)